For instance, NLY01, a long-acting PEGylated GLP-1RA with an extended half-life [41], effectively mitigates retinal ganglion cell (RGC) apoptosis induced by elevated intraocular pressure, a process mediated by a well-defined inflammatory cascade [44]
Always follow your specific prescription over any general guide
Stay informed and hear the full discussion on the BamCam Podcast
No Screens in Bed Screen usage has become so deeply embedded in our lifestyles that, in many cases, we hardly notice the disruptive effects that come with smartphones and other devices
Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care
GLP-1 receptor agonists are used in accordance with NICE guidance for managing type 2 diabetes (NG28) and, in defined circumstances, for weight management (TA875)